/ /

Keith Loria
Keith Loria is a contributing writer to Medical Economics.
Can anything be done to solve the PCP shortage crisis?
Last year, just one in 10 U.S. medical school graduates went into family medicine and the Association of American Medical Colleges predicts that the U.S. will be short by as many as 43,000 primary care doctors by 2030.
What’s new in updated brachytherapy guideline
The update provides evidence-based recommendations for different patient risk groups and specifies the most effective forms of the treatment for patients with prostate cancer.
What the Obamacare repeal bill means for physicians
What the Obamacare repeal bill means for physicians
The new bill looks to change how healthcare is financed for people who do not have insurance through their employer, and would eliminate the mandate requiring all Americans to carry health insurance.
What a Gorsuch Supreme Court appointment could mean to healthcare
What a Gorsuch Supreme Court appointment could mean to healthcare
Physicians have mixed feelings about Donald Trump’s nominee.
Top MACRA apps physicians need to download
A look at apps that can help physicians in the transition to value-based Medicare reimbursement
Should physicians share their notes with patients?
Should physicians share their notes with patients?
How allowing patients to read notes can strengthen the bond for a physician.
Rheumatologic side effects possible with immunotherapies
Cancer patients taking certain immunotherapy drugs may be more susceptible to developing autoimmune joint and tissue diseases, including inflammatory arthritis, according to a recent study.
Health IT creates lose-lose situation for physicians
Health IT creates lose-lose situation for physicians
Patients are torn between whether they want their physicians to use technology or not.
Trump attempts market stabilization of Obamacare
Trump attempts market stabilization of Obamacare
What the proposed changes mean to physicians.
Genetic predictors could improve PSA accuracy
A recent study has found that genetic predictors of normal PSA levels in healthy men could be used to improve the accuracy of PSA-based prostate cancer screening.